Blue Skies Bluer?

Area of Science:

• Environmental Health
• Epidemiology
• Public Policy

Background:

• Ambient fine particulate matter (PM2.5) is a major U.S. environmental health risk, primarily causing cardiopulmonary mortality.
• Current air quality policy often assumes a linear concentration-response (C-R) relationship for PM2.5 health impacts.
• Emerging evidence suggests a potentially supralinear C-R, where health benefits increase disproportionately as PM2.5 concentrations decrease.

Purpose of the Study:

• To explore the implications of a supralinear PM2.5 C-R relationship for U.S. air quality policy.
• To evaluate how supralinearity affects economically efficient PM2.5 targets.
• To assess the potential for greater health improvements with more stringent PM2.5 standards.

Main Methods:

• Analysis of the concentration-response function for PM2.5 and cardiopulmonary mortality.
• Modeling the impact of linear versus supralinear C-R relationships on health outcomes.
• Economic evaluation of air policy targets under different C-R assumptions.

Main Results:

• A supralinear C-R suggests that achieving greater health benefits requires more stringent PM2.5 reductions.
• Under a supralinear model, the current U.S. EPA standard of 12 μg/m³ would avert only an estimated 17% of annual cardiopulmonary mortality.
• In contrast, a linear C-R model estimates averting approximately 25% of mortality at the same standard.

Conclusions:

• If the PM2.5 C-R is supralinear, economically efficient air quality targets should be significantly more stringent than current standards.
• Prioritizing emission reductions in cleaner areas could maximize health gains but may conflict with environmental equity.
• Substantial health benefits are achievable by reducing U.S. PM2.5 levels well below existing standards, regardless of the C-R linearity.